Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04454723 · ClinicalTrials.gov registry record · NA
Impact of Palliative Transfusions on Quality of Life in Patients With Blood Cancers on Hospice
A NA study, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04454723 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 20 participants.
The verdict
NCT04454723, a NA study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this pilot research study is to evaluate the effectiveness of blood and platelet transfusions in improving symptoms and quality of life of patients enrolled in hospice.
Interventions
- PROCEDURE Blood and/or platelet transfusion
- PROCEDURE Complete blood count (CBC) collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-08-14 |
| Est. Completion | 2023-08-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04454723
The ClinicalTrials.gov registry entry for NCT04454723 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood and/or platelet transfusion is the first listed.
NCT04454723 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04454723 about?
NCT04454723 is a clinical study titled "Impact of Palliative Transfusions on Quality of Life in Patients With Blood Cancers on Hospice". The purpose of this pilot research study is to evaluate the effectiveness of blood and platelet transfusions in improving symptoms and quality of life of patients enrolled in hospice.
What is the current status of trial NCT04454723?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2020-08-14. Estimated completion is 2023-08-17.
What interventions are being tested in trial NCT04454723?
The interventions under investigation include: Blood and/or platelet transfusion (PROCEDURE), Complete blood count (CBC) collection (PROCEDURE).
Who is sponsoring clinical trial NCT04454723?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.